Russia’s first access program for the drug will provide treatment to 80 patients from the country’s leading oncology ...

ChemRar Group and Pharmaceutical Health Corporation S.A.S, national pharmaceutical distributor in Colombia, announce ...

Actualmente, ChemRar y la empresa mexicana «Distribuidora y Exportadora de Medicamentos, S.A. de C.V. (DIEMSA)» han ...

Favipiravir, developed in Japan to treat influenza and other RNA-viral infections, in 2020–2022 was widely used to ...